Patents Assigned to Robert Toppo
  • Patent number: 6048903
    Abstract: The level of heavy density lipoproteins (HDL) in the blood of a human subject can be in eased by administering dosages of between 50 and 1,000 milligrams of trans-resveratrol to the subject daily. This same dosage reduces the level of light density lipoproteins (LDL) in the blood of the subject. By increasing the blood level of HDL and decreasing the blood level of LDL in the subject, the risk of hypercholesterolemia in the subject is reduced.
    Type: Grant
    Filed: May 3, 1994
    Date of Patent: April 11, 2000
    Assignees: Robert Toppo, Shaina Toppo
    Inventor: Frank Toppo